Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Illumina, Inc. (NASDAQ: ILMN), and Ovation.io, Inc., an organization dedicated to building best-in-class multiomics datasets, today announced the development of the largest commercially available ...

Researchers have identified GLP-1 receptor agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as ...

Worldwide’s Alessandra Vignola and Natalia Castro will share emerging study trends and strategies at the GLP-1-Based ...

Mum-of-three Mary lost a substantial amount of weight on Mounjaro - but noticed one significant symptom return as soon as she ...

Ten years later, he built on that research by demonstrating how this naturally occurring peptide could also suppress appetite ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Lexaria's experience with other GLP-1 drugs to date in humans ... competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...